Target intelligence / Profile preview

Eomesodermin (EOMES)

Target
EOMES
Molecular classification
Transcription factor, T-box family
01

Overview

Eomesodermin (EOMES) is a T-box transcription factor essential in early mammalian embryogenesis and immune cell lineage specification. In embryonic development, it plays a pivotal role in specifying extraembryonic lineages such as the trophectoderm and in the sequential specification of mesodermal derivatives required for heart, yolk sac, and endoderm formation[1][2]. EOMES regulates the maintenance of trophoblast stem cells, supports epithelial to mesenchymal transition, and partners with other transcription factors and chromatin-modifying complexes to maintain chromatin accessibility at lineage-specific genes[1]. In the immune system, EOMES is critical for the differentiation, effector functions, and memory formation of CD8+ T lymphocytes, integrating extracellular signals and driving expression of genes such as interferon-γ, perforin, and granzyme B[3]. Disruption of EOMES leads to developmental arrest in embryos and can skew immune cell fate decisions, underlining its essential regulatory roles across multiple biological contexts[1][2][3].

Other names
Eomesodermin homologEOMESTBR2T-brain-2T-box brain protein 2T-box brain2TBR-2
02

Biological functions

Cell fate specification in embryogenesisRegulation of trophectoderm maintenanceEpithelial to mesenchymal transition during gastrulationDifferentiation and effector function of CD8+ T lymphocytesRegulation of gene expression networks in progenitor and stem cells
03

Disease associations

CancerDevelopmental disordersImmune dysregulationCardiovascular disease (via embryonic lineage defects)
04

Safety considerations

Potential for developmental arrest if disruptedRisk of immune dysregulation if dysregulated in lymphocytes

Beyond the preview

Go deeper on Eomesodermin (EOMES).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eomesodermin (EOMES).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call